Edition:
United Kingdom

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

10.81USD
20 Nov 2017
Change (% chg)

$-0.38 (-3.40%)
Prev Close
$11.19
Open
$11.13
Day's High
$11.26
Day's Low
$10.66
Volume
16,338
Avg. Vol
27,321
52-wk High
$15.75
52-wk Low
$5.48

Select another date:

Mon, Nov 13 2017

BRIEF-Ra Capital Management says it purchased 850,000 shares of Kalvista Pharmaceuticals' common stock for about $7.2 mln

* Ra Capital Management says ‍​on Oct 12, it purchased 850,000 shares of Kalvista Pharmaceuticals' common stock for about $7.2 million - SEC Filing

BRIEF-Longwood Fund II reports 8.7 pct stake in Kalvista Pharmaceuticals ‍​

* Longwood Fund II Lp reports 8.7 pct stake in Kalvista Pharmaceuticals Inc as of Oct 12 - sec filing‍​ Source text - http://bit.ly/2xTHJJO Further company coverage:

BRIEF-Kalvista Pharmaceuticals announces collaboration with Merck

* Kalvista Pharmaceuticals announces collaboration with Merck

BRIEF-KalVista Pharmaceuticals reports Q1 loss per share of $0.51

* KalVista pharmaceuticals reports fiscal first quarter results

BRIEF-Kalvista Pharmaceuticals reports Q4 loss per share $0.43

* Kalvista Pharmaceuticals provides operational update and reports fiscal fourth quarter and full year financial results

BRIEF-Kalvista Pharmaceuticals enters into an at-market sales agreement with BTIG

* Kalvista Pharmaceuticals Inc - on July 13, 2017 co entered into an at--market sales agreement with BTIG, LLC

Select another date: